{"id":"W1512461647","doi":"10.1067/mhj.2000.105107","title":"Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial","year":2000,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Eptifibatide; Myocardial infarction; Cardiology; Internal medicine; Stroke (engine); Vascular disease; Ticlopidine; Platelet activation; Unstable angina; Thienopyridine; Platelet aggregation inhibitor; Pharmacology; Platelet; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000351712,0.0001368624,0.0004676482,0.00005438497,0.00020722,0.000009573399,0.0001888526,0.00004029281,0.0008381358],"category_scores_gemma":[0.0001186271,0.00007008601,0.0003218686,0.0004463487,0.0001890576,0.00003288721,0.00004543297,0.0002874466,0.0000314884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005659629,"about_ca_system_score_gemma":0.0002318532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003232429,"about_ca_topic_score_gemma":0.000004914495,"domain_scores_codex":[0.9983994,0.0003039947,0.0003847347,0.0001420547,0.0005287617,0.0002410812],"domain_scores_gemma":[0.9991465,0.0000697158,0.0001928041,0.0003742099,0.00007505083,0.0001417028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08423804,0.005180249,0.03556188,0.0001050658,0.002329669,0.0002138287,0.005863326,0.003004359,0.579406,0.00001795123,0.04203962,0.24204],"study_design_scores_gemma":[0.1738339,0.03267176,0.1677251,0.003278852,0.002271313,0.006193918,0.002186544,0.0007411711,0.4603403,0.001087115,0.1482772,0.001392841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946096,0.0001882579,0.0001079095,0.003822153,0.0001719471,0.0009135408,0.000005629697,0.000007022328,0.000173934],"genre_scores_gemma":[0.9960766,0.0001704218,0.002181259,0.0008564098,0.0001585881,0.000008268988,6.853766e-7,0.00001958902,0.0005282044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2406472,"threshold_uncertainty_score":0.9176999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01546911632974345,"score_gpt":0.2697006930554746,"score_spread":0.2542315767257312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}